Estimating the Economic Benefits from the Cognitive Regulation Training and Exercise (CORTEX)-II Program

preprint OA: closed CC-BY-4.0
🔓 Open OA copy View at publisher

Abstract

Physical inactivity is a significant contributor to chronic diseases, leading to substantial healthcare burdens globally. This study provides a cost-benefit analysis of the COgnitive Regulation Training and EXercise (CORTEX) program, a novel, multimodal, games-based intervention designed to stimulate physical activity participation among middle-aged adults. Implemented as a 20-hour training program, half in a laboratory setting and half at home, the participants also received a year-long fitness membership and a Fitbit device. They were prescribed to meet or exceed 150 minutes of moderate-intensity physical activity per week. The effectiveness of the CORTEX program was evaluated in a randomized controlled trial against an attentional control video condition. The primary aim was to determine the intervention's impact on sustained exercise behavior. A higher percentage of participants in the intervention group met the recommended physical activity guidelines, indicating the potential of the intervention as a health-promoting tool. The gross economic benefits of the program were estimated at $127,914, underlining the substantial potential of our intervention. The cost-benefit analysis revealed a per-participant net economic benefit of $249.76 for the intervention group, compared to $312.76 for the control group. Although the intervention group's net economic benefit was lower due to the added costs of the video game units, it demonstrated a higher adherence rate to physical activity guidelines. This suggests the potential for significant long-term health benefits and healthcare cost savings, thus supporting the intervention's financial viability and scalability. These findings underscore that game-based interventions like CORTEX may serve as effective, cost-conscious strategies to combat the public health issue of physical inactivity, providing valuable insights for translational behavioral medicine.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-05-19T01:45:01.086888+00:00
unpaywall
last seen: 2026-06-06T02:00:05.402940+00:00
License: CC-BY-4.0